Familial ligand-defective apolipoprotein B (apoB) is a group of disorders c
aused by mutations in the apoB gene, In this report the R3531C mutation is
characterized further using a monoclonal antibody MB19/dynamic laser light
scattering technique to measure ratios of Cys(3531) to normal low density l
ipoprotein (LDL) particles. All six subjects studied showed a preferential
accumulation of particles carrying the defective apoB allotype, We determin
ed binding properties of LDL from R3531C heterozygotes by measurement of hi
gh-affinity binding to LDL receptors on fibroblasts and its ability promote
growth of U937 cells. LDL from R3531C heterozygotes, compared to normal LD
L, had 49.3% of the binding affinity and was 74% as effective in a U937 cel
l proliferation assay. To identify new probands, we screened 2570 subjects
for the R3531C mutation. Nine probands were found with 15 affected relative
s. Of the seven haplotypes we uncovered, two were novel, while five were id
entical to one initially reported as associated with Cys3531. Three silent
mutations were detected also: T3540T, N3542N and T3552T. Analysis of lipid
profiles of R3531C families showed, as with the R3500Q mutation, variable e
xpression of the phenotype, modulated by environmental and other genetic fa
ctors. Both mutations tend to produce lower plasma levels of LDL in affecte
d subjects than do defects of the LDL receptor (familial hypercholesterolem
ia, FH). This study shows that the Cys3531 LDL particles are not only defec
tive at binding to the LDL receptor, as determined by two separate methods,
but that in all cases they accumulate preferentially compared to the norma
l allotype.